cerrar
Tagged with Global

Global Pharma Sales & Price Projections 2022
Pharmaceutical sales are expected to rise by 4.9 percent in 2022 according to the Economist Intelligence Unit (EIU) with the US continuing to lead the…

Novartis Announces Major Restructuring to “Power Next Phase”
Exactly five months after concluding that it was the right time to “monetize” its investment in a cross-town rival – providing Roche “full…

Five Trends to Watch in Global Healthcare and Life Sciences in…
In 2022 global healthcare will continue to feel the effects of the pandemic and although COVID-19 has become less virulent, with the global death rate…

Pierluigi Antonelli – CEO, Angelini Pharma
Speaking exclusively to PharmaBoardroom, Pierluigi Antonelli outlines Angelini Pharma's progress in transforming from a traditional, Italy-focused,…

Gianfranco Nazzi – CEO, Almirall
Almirall CEO Gianfranco Nazzi dives into the new strategic focus of the global biopharmaceutical company with HQ in Barcelona as it seeks to serve the…

Top COVID-19 Vaccines By Revenue 2021-22
The top COVID-19 Vaccines by revenue in 2021 and sales projections for 2022 based on Airfinity's COVID-19 Vaccine Market Revenue Forecast 2022.…

Sanofi’s ‘Play to Win’ Transformation Reaping Dividends…
When British executive Paul Hudson joined French pharma Sanofi back in 2019, he was quick to launch a “play to win” strategy, shedding…

Women’s Health Giant Organon Looks to Future Growth
In June 2021, as part of a broader restructuring, Merck (MSD globally) spun off its women’s health, legacy products, and biosimilars businesses. The…

Mario Rovirosa – CEO, Ferrer
Ferrer’s CEO, Mario Rovirosa, outlines how he and a new management team have been building the foundation of the Spanish mid-cap’s transformation…

Top Biotech VC Investors 2021
Based on analysis from Crunchbase, read on for 2021's largest VC investments into the biotech industry (which topped USD 65 billion last year) and…

The Biopharmaceutical Industry’s Three Priorities to…
As the focus of the global COVID-19 pandemic response shifts downstream from the development and production of vaccines to vaccination campaigns…

Steven Hildemann, MD, PHD – EVP, Chief Medical Officer,…
Two years into his role, Ipsen’s EVP and Chief Medical Officer Prof. Dr. med. Steven Hildemann MD discusses his vision of patient-centricity and how…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here